Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial
Richard S.E. Keefe(Duke Medical Center), T. Scott Stroup(New York Psychoanalytic Society and Institute), Robert M. Hamer(University of North Carolina at Chapel Hill), Alice Medalia(Columbia University Irving Medical Center), Stanley N. Caroff(California University of Pennsylvania), Del D. Miller(University of Iowa), Sophia Vinogradov(University of Minnesota), Jayendra K. Patel(University of Massachusetts Chan Medical School), Dawn I. Velligan(The University of Texas at San Antonio Health Science Center), P.F. Buckley(University of Tennessee Health Science Center), P.D. Harvey(University of Miami), Deepak Cyril D’Souza(Yale University), Karen A. Graham(University of Surrey), Stephen Marder(University of California, Los Angeles), Adam Haim(National Institutes of Health), Trina M. Walker(Duke University), Stephen J. Olson(University of Minnesota)
Cited by 97
Related Papers
Persistent cannabis users show neuropsychological decline from childhood to midlife
|Proceedings of the National Academy of Sciences|2012|1.5k
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
Self-report measures of medication adherence behavior: recommendations on optimal use
|Translational Behavioral Medicine|2015|832